Suven Life Sciences Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 11.09 | 8.30 | 5.57 |
| Operating Expense | 24.58 | 17.72 | 17.70 |
| Net Profit | -16.12 | -11.17 | -13.47 |
| Net Profit Margin | -145.36% | -134.58% | -241.83% |
| Earning Per Share | -0.61 | -0.50 | -0.60 |
| EBIDTA | -13.48 | -9.43 | -12.12 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Jun 2026
Revenue11.09
Operating Expense24.58
Net Profit-16.12
Net Profit Margin-145.36
Earning Per Share-0.61
EBIDTA-13.48
Effective Tax Rate-0
